Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1. | Br J Dermatol;190(2): 145-146, 2024 Jan 23. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Toward risk stratification and personalized therapy for neurofibromas in neurofibromatosis type 1.

Romo, Carlos G; Sarin, Kavita Y; Blakeley, Jaishri O.

Affiliation

Romo CG; Department of Neurology, Johns Hopkins University, Baltimore, MD.
Sarin KY; Department of Dermatology, Stanford University School of Medicine, Stanford, CA, USA.
Blakeley JO; Department of Neurology, Johns Hopkins University, Baltimore, MD.

Br J Dermatol ; 190(2): 145-146, 2024 Jan 23.

Article in En | MEDLINE | ID: mdl-38123358

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Neurofibromatosis 1 / Neurofibroma Limits: Humans Language: En Journal: Br J Dermatol Year: 2024 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Neurofibromatosis 1 / Neurofibroma Limits: Humans Language: En Journal: Br J Dermatol Year: 2024 Document type: Article Affiliation country: